Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
338 studies found for:    "Genital Diseases, Female" | Canada
Show Display Options
Rank Status Study
1 Completed Comparing Combination Chemotherapy Regimens in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer;   Metastatic Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: paclitaxel;   Procedure: quality-of-life assessment
2 Completed Comparison of Combination Chemotherapy Regimens in Treating Newly Diagnosed Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: paclitaxel;   Drug: topotecan hydrochloride
3 Completed ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: ISIS 5132
4 Completed Radiation Therapy or Observation Only in Treating Patients With Endometrial Cancer Who Have Undergone Surgery
Condition: Endometrial Cancer
Intervention: Radiation: radiation therapy
5 Completed Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis
Conditions: Atrophic Vaginitis;   Atrophy;   Vaginitis
Interventions: Drug: PVC (daily for 21 days, 7 days off);   Drug: PVC (twice weekly)
6 Unknown  Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Intervention: Biological: oregovomab
7 Recruiting Radical Versus Simple Hysterectomy and Pelvic Node Dissection in Patients With Low-risk Early Stage Cervical Cancer (SHAPE)
Condition: Cervical Cancer
Interventions: Procedure: Radical Hysterectomy + pelvic lymph node dissection;   Procedure: Simple hysterectomy + pelvic lymph node dissection
8 Completed
Has Results
Somatropin Treatment to Final Height in Turner Syndrome
Condition: Turner Syndrome
Interventions: Drug: Somatropin;   Drug: Ethinyl estradiol;   Drug: Medroxyprogesterone acetate
9 Completed Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Interventions: Drug: carboplatin;   Drug: cisplatin;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
10 Active, not recruiting A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)
Conditions: Ovarian Cancer;   Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Cancer
Intervention: Drug: Oral rucaparib
11 Completed Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: ridaforolimus;   Genetic: gene expression analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
12 Completed Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Kidney Cancer;   Ovarian Cancer;   Pheochromocytoma;   Sarcoma
Interventions: Biological: filgrastim;   Drug: doxorubicin hydrochloride;   Drug: ifosfamide;   Drug: isolated perfusion;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Radiation: radiation therapy
13 Active, not recruiting TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cancer
Interventions: Drug: AMG 386;   Drug: Paclitaxel;   Drug: AMG 386 Placebo;   Drug: Carboplatin
14 Completed Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil vs Vardenafil PRN vs Placebo in Men Immediately After Nerve-sparing Prostatectomy for Improving ED
Conditions: Erectile Dysfunction;   Sexual Dysfunction, Physiological
Interventions: Drug: Levitra (Vardenafil, BAY38-9456);   Drug: Placebo
15 Completed
Has Results
Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)
Condition: Menorrhagia
Interventions: Drug: Levonorgestrel IUS (Mirena, BAY86-5028);   Drug: Medroxyprogesterone acetate
16 Recruiting Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Ovarian Brenner Tumor;   Ovarian Carcinosarcoma;   Ovarian Clear Cell Cystadenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mucinous Cystadenocarcinoma;   Ovarian Seromucinous Carcinoma;   Ovarian Serous Cystadenocarcinoma;   Ovarian Serous Surface Papillary Adenocarcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Undifferentiated Ovarian Carcinoma
Interventions: Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Other: Placebo;   Drug: WEE1 Inhibitor AZD1775
17 Completed Pain Associated With Endometriosis
Condition: Endometriosis
Interventions: Drug: Danazol Once Weekly;   Drug: Danazol Twice Weekly;   Drug: Placebo Once Weekly;   Drug: Placebo Twice Weekly
18 Completed
Has Results
Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes
Condition: Genital Herpes
Interventions: Drug: Famciclovir;   Drug: Valacyclovir;   Drug: Placebo matching famciclovir;   Drug: Placebo matching valacyclovir
19 Completed
Has Results
Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding
Condition: Metrorrhagia
Interventions: Drug: Estradiol valerate/Dienogest (Natazia, Qlaira, BAY86-5027);   Drug: Placebo
20 Completed Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Stage IB Cervical Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer
Interventions: Drug: cisplatin;   Drug: tirapazamine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years